Skip to main content

Advertisement

Log in

Practical Approaches to the Treatment of Neonatal Seizures

  • Pediatric Neurology (A Yeshokumar, Section Editor)
  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Abstract

Purpose of review

This paper critically reviews the current literature and evidence on diagnosis, classification, clinical approach, and management of neonatal seizures. A stepwise approach for the treatment of neonatal seizures is presented.

Recent findings

In a recent randomized controlled trial comparing phenobarbital to levetiracetam as a first-choice anti-seizure medication with primary outcome seizure free for 24 h, the former was found superior (80% vs 28%, p < 0.001).

Summary

Neonatal seizures require immediate diagnostic and therapeutic interventions. Phenobarbital is the first-line anti-seizure drug for neonatal seizures, but there is little evidence regarding second-line pharmacotherapy. There is a need for more randomized controlled trials for the use of other existing anti-seizure drugs, yet unlicensed in neonates, and the development of new drugs specifically for neonates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Vasudevan C, Levene M. Epidemiology and aetiology of neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):185–91.

    Article  PubMed  Google Scholar 

  2. Malone A, Ryan CA, Fitzgerald A, Burgoyne L, Connolly S, Boylan GB. Interobserver agreement in neonatal seizure identification. Epilepsia. 2009;50(9):2097–101.

    Article  PubMed  Google Scholar 

  3. Tsuchida TN, Wusthoff CJ, Shellhaas RA, Abend NS, Hahn CD, Sullivan JE, et al. American clinical neurophysiology society standardized EEG terminology and categorization for the description of continuous EEG monitoring in neonates: report of the American Clinical Neurophysiology Society critical care monitoring committee. J Clin Neurophysiol. 2013;30(2):161–73.

    Article  PubMed  Google Scholar 

  4. Shellhaas RA, Chang T, Tsuchida T, Scher MS, Riviello JJ, Abend NS, et al. The American Clinical Neurophysiology Society’s guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol. 2011;28(6):611–7.

    Article  PubMed  Google Scholar 

  5. Pisani F, Copioli C, Di Gioia C, Turco E, Sisti L. Neonatal seizures: relation of ictal video-electroencephalography (EEG) findings with neurodevelopmental outcome. J Child Neurol. 2008;23(4):394–8.

    Article  PubMed  Google Scholar 

  6. Uria-Avellanal C, Marlow N, Rennie JM. Outcome following neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):224–32.

    Article  PubMed  Google Scholar 

  7. Shah DK, Wusthoff CJ, Clarke P, Wyatt JS, Ramaiah SM, Dias RJ, et al. Electrographic seizures are associated with brain injury in newborns undergoing therapeutic hypothermia. Arch Dis Child Fetal Neonatal Ed. 2014;99(3):F219–24.

    Article  PubMed  Google Scholar 

  8. Pisani F, Cerminara C, Fusco C, Sisti L. Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome. Neurology. 2007;69(23):2177–85.

    Article  PubMed  Google Scholar 

  9. Payne ET, Zhao XY, Frndova H, McBain K, Sharma R, Hutchison JS, et al. Seizure burden is independently associated with short term outcome in critically ill children. Brain. 2014;137(Pt 5):1429–38.

    Article  PubMed  PubMed Central  Google Scholar 

  10. van Rooij LG, Toet MC, van Huffelen AC, Groenendaal F, Laan W, Zecic A, et al. Effect of treatment of subclinical neonatal seizures detected with aEEG: randomized, controlled trial. Pediatrics. 2010;125(2):e358–66.

    Article  PubMed  Google Scholar 

  11. • Kharoshankaya L, Stevenson NJ, Livingstone V, Murray DM, Murphy BP, Ahearne CE, et al. Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy. Dev Med Child Neurol. 2016;58(12):1242–8. This study is one of the most important ones to demonstrate the association of seizure burden with neurodevelopmental outcome independent to the intervention of therapeutic hypothermia, comparing two cohorts of neonates pre and post - cooling era.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Glass HC, Glidden D, Jeremy RJ, Barkovich AJ, Ferriero DM, Miller SP. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr. 2009;155(3):318–23.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A. 2002;99(23):15089–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Forcelli PA, Janssen MJ, Vicini S, Gale K. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol. 2012;72(3):363–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kaushal S, Tamer Z, Opoku F, Forcelli PA. Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain. Epilepsia. 2016;57(5):727–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ronen GM, Penney S, Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr. 1999;134(1):71–5.

    Article  CAS  PubMed  Google Scholar 

  17. Glass HC, Pham TN, Danielsen B, Towner D, Glidden D, Wu YW. Antenatal and intrapartum risk factors for seizures in term newborns: a population-based study, California 1998–2002. J Pediatr. 2009;154(1):24–8 e1.

  18. Weeke LC, Groenendaal F, Toet MC, Benders MJ, Nievelstein RA, van Rooij LG, et al. The aetiology of neonatal seizures and the diagnostic contribution of neonatal cerebral magnetic resonance imaging. Dev Med Child Neurol. 2015;57(3):248–56.

    Article  PubMed  Google Scholar 

  19. Janackova S, Boyd S, Yozawitz E, Tsuchida T, Lamblin MD, Gueden S, et al. Electroencephalographic characteristics of epileptic seizures in preterm neonates. Clin Neurophysiol. 2016;127(8):2721–7.

    Article  PubMed  Google Scholar 

  20. Glass HC, Shellhaas RA, Wusthoff CJ, Chang T, Abend NS, Chu CJ, et al. Contemporary profile of seizures in neonates: a prospective cohort study. J Pediatr. 2016;174:98–103 e1.

  21. • Pellegrin S, Munoz FM, Padula M, Heath PT, Meller L, Top K, et al. Neonatal seizures: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2019;37(52):7596–609. The Brighton collaboration has produced an algorithm which defines which defines distinct levels of diagnostic certainties according to availability of diagnostic tests, such as EEG and is presented in this paper.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mizrahi EM, Kellaway P. Characterization and classification of neonatal seizures. Neurology. 1987;37(12):1837–44.

    Article  CAS  PubMed  Google Scholar 

  23. Painter MJ, Scher MS, Stein AD, Armatti S, Wang Z, Gardiner JC, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341(7):485–9.

    Article  CAS  PubMed  Google Scholar 

  24. Murray DM, Boylan GB, Ali I, Ryan CA, Murphy BP, Connolly S. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed. 2008;93(3):F187–91.

    Article  CAS  PubMed  Google Scholar 

  25. Clancy RR, Legido A, Lewis D. Occult neonatal seizures. Epilepsia. 1988;29(3):256–61.

    Article  CAS  PubMed  Google Scholar 

  26. Biagioni E, Ferrari F, Boldrini A, Roversi MF, Cioni G. Electroclinical correlation in neonatal seizures. Eur J Paediatr Neurol. 1998;2(3):117–25.

    Article  CAS  PubMed  Google Scholar 

  27. Boylan GB, Pressler RM, Rennie JM, Morton M, Leow PL, Hughes R, et al. Outcome of electroclinical, electrographic, and clinical seizures in the newborn infant. Dev Med Child Neurol. 1999;41(12):819–25.

    Article  CAS  PubMed  Google Scholar 

  28. Boylan GB, Rennie JM, Pressler RM, Wilson G, Morton M, Binnie CD. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed. 2002;86(3):F165–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Scher MS, Alvin J, Gaus L, Minnigh B, Painter MJ. Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use. Pediatr Neurol. 2003;28(4):277–80.

    Article  PubMed  Google Scholar 

  30. Nash KB, Bonifacio SL, Glass HC, Sullivan JE, Barkovich AJ, Ferriero DM, et al. Video-EEG monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Neurology. 2011;76(6):556–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Nagarajan L, Ghosh S, Palumbo L. Ictal electroencephalograms in neonatal seizures: characteristics and associations. Pediatr Neurol. 2011;45(1):11–6.

    Article  PubMed  Google Scholar 

  32. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361(14):1349–58.

    Article  CAS  PubMed  Google Scholar 

  33. Boylan GB, Kharoshankaya L, Wusthoff CJ. Seizures and hypothermia: importance of electroencephalographic monitoring and considerations for treatment. Semin Fetal Neonatal Med. 2015;20(2):103–8.

    Article  PubMed  Google Scholar 

  34. Pavel AM, Rennie JM, de Vries LS, Blennow M, Foran A, Shah DK, et al. A machine-learning algorithm for neonatal seizure recognition: a multicentre, randomised, controlled trial. Lancet Child Adolesc Health. 2020;4(10):740–9.

    Article  PubMed  PubMed Central  Google Scholar 

  35. • Wusthoff CJ, Sundaram V, Abend NS, Massey SL, Lemmon ME, Thomas C, et al. Seizure control in neonates undergoing screening vs confirmatory EEG monitoring. Neurology. 2021;97(6):e587–96. Important work demonstrating the superiority of screening cEEG versus confirmatory cEEG for the effective treatment of neonatal seizures.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Tharp BR. Unique EEG pattern (comb-like rhythm) in neonatal maple syrup urine disease. Pediatr Neurol. 1992;8(1):65–8.

    Article  CAS  PubMed  Google Scholar 

  37. Low E, Mathieson SR, Stevenson NJ, Livingstone V, Ryan CA, Bogue CO, et al. Early postnatal EEG features of perinatal arterial ischaemic stroke with seizures. PLoS One. 2014;9(7):e100973.

  38. Serino D, Specchio N, Pontrelli G, Vigevano F, Fusco L. Video/EEG findings in a KCNQ2 epileptic encephalopathy: a case report and revision of literature data. Epileptic Disord. 2013;15(2):158–65.

    Article  PubMed  Google Scholar 

  39. Awal MA, Lai MM, Azemi G, Boashash B, Colditz PB. EEG background features that predict outcome in term neonates with hypoxic ischaemic encephalopathy: a structured review. Clin Neurophysiol. 2016;127(1):285–96.

    Article  PubMed  Google Scholar 

  40. Co JP, Elia M, Engel J Jr, Guerrini R, Mizrahi EM, Moshe SL, et al. Proposal of an algorithm for diagnosis and treatment of neonatal seizures in developing countries. Epilepsia. 2007;48(6):1158–64.

    Article  PubMed  Google Scholar 

  41. Rakshasbhuvankar A, Paul S, Nagarajan L, Ghosh S, Rao S. Amplitude-integrated EEG for detection of neonatal seizures: a systematic review. Seizure. 2015;33:90–8.

    Article  PubMed  Google Scholar 

  42. Zhang L, Zhou YX, Chang LW, Luo XP. Diagnostic value of amplitude-integrated electroencephalogram in neonatal seizures. Neurosci Bull. 2011;27(4):251–7.

    Article  PubMed  PubMed Central  Google Scholar 

  43. •• Pressler RM, Cilio, M. R., Mizrahi, E.M., Moshe, S.L., Lunes, M.L., Plouin, P., Vanhatalo, S., Yozawitz, E., de Vries, L.S., Vinayan, K., P., Triki, C., C., Wilmshurst, J.M., Yamatomo, H., Zuberi, S.M. The ILAE classification of seizures & the epilepsies: modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia. 2020. Groundwork on the new classification of neonatal seizures.

  44. Volpe JJ. Neurology of the newborn: neonatal seizures. 5th ed. Philadelphia: Saunders Esevier; 2008. p. 203.

    Book  Google Scholar 

  45. Nagarajan L, Palumbo L, Ghosh S. Classification of clinical semiology in epileptic seizures in neonates. Eur J Paediatr Neurol. 2012;16(2):118–25.

    Article  PubMed  Google Scholar 

  46. Milh M, Boutry-Kryza N, Sutera-Sardo J, Mignot C, Auvin S, Lacoste C, et al. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2. Orphanet J Rare Dis. 2013;8:80.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Zara F, Specchio N, Striano P, Robbiano A, Gennaro E, Paravidino R, et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Epilepsia. 2013;54(3):425–36.

    Article  CAS  PubMed  Google Scholar 

  48. World Health Organisation W. Guidelines on neonatal seizures. Geneva 2011.

  49. Evans DJ, Levene MI, Tsakmakis M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst Rev. 2007(3):CD001240.

  50. • Soul JS, Pressler R, Allen M, Boylan G, Rabe H, Portman R, et al. Recommendations for the design of therapeutic trials for neonatal seizures. Pediatr Res. 2019;85(7):943–54. Important paper on the design of drug trials for neonatal seizures.

    Article  PubMed  Google Scholar 

  51. Sankar R, Painter MJ. Neonatal seizures: after all these years we still love what doesn’t work. Neurology. 2005;64(5):776–7.

    Article  PubMed  Google Scholar 

  52. Silverstein FS, Ferriero DM. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol. 2008;39(2):77–9.

    Article  PubMed  Google Scholar 

  53. Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci. 2003;993:103–14; discussion 23–4.

  54. Forcelli PA, Kim J, Kondratyev A, Gale K. Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain. Epilepsia. 2011;52(12):e207–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Boylan GB, Rennie JM, Chorley G, Pressler RM, Fox GF, Farrer K, et al. Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study. Neurology. 2004;62(3):486–8.

    Article  CAS  PubMed  Google Scholar 

  56. Booth D, Evans DJ. Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev. 2004(4):CD004218.

  57. •• Sharpe C, Reiner GE, Davis SL, Nespeca M, Gold JJ, Rasmussen M, et al. Levetiracetam versus phenobarbital for neonatal seizures: a randomized controlled trial. Pediatrics. 2020;145(6). The most recent randomised controlled trial using cEEG and demonstrating superiority of phenobarbital versus levetiracetam in achieving seizure freedom for 24 hours.

  58. McHugh DC, Lancaster S, Manganas LN. A systematic review of the efficacy of levetiracetam in neonatal seizures. Neuropediatrics. 2018;49(1):12–7.

    Article  CAS  PubMed  Google Scholar 

  59. Gowda VK, Romana A, Shivanna NH, Benakappa N, Benakappa A. Levetiracetam versus phenobarbitone in neonatal seizures - a randomized controlled trial. Indian Pediatr. 2019;56(8):643–6.

    Article  PubMed  Google Scholar 

  60. Loiacono G, Masci M, Zaccara G, Verrotti A. The treatment of neonatal seizures: focus on Levetiracetam. J Matern Fetal Neonatal Med. 2016;29(1):69–74.

    Article  CAS  PubMed  Google Scholar 

  61. National Institute for Health and Care of Excellence N. British National Formulary (BNF) for children. 2021.

  62. de Haan TR, Bijleveld YA, van der Lee JH, Groenendaal F, van den Broek MP, Rademaker CM, et al. Pharmacokinetics and pharmacodynamics of medication in asphyxiated newborns during controlled hypothermia. The PharmaCool multicenter study BMC Pediatr. 2012;12:45.

    Article  PubMed  CAS  Google Scholar 

  63. Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J. Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol. 2011;15(1):1–7.

    Article  PubMed  Google Scholar 

  64. Abend NS, Gutierrez-Colina AM, Monk HM, Dlugos DJ, Clancy RR. Levetiracetam for treatment of neonatal seizures. J Child Neurol. 2011;26(4):465–70.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Hanon E, Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure. 2001;10(4):287–93.

    Article  CAS  PubMed  Google Scholar 

  67. Kilicdag H, Daglioglu K, Erdogan S, Guzel A, Sencar L, Polat S, et al. The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev. 2013;89(5):355–60.

    Article  CAS  PubMed  Google Scholar 

  68. Griesmaier E, Stock K, Medek K, Stanika RI, Obermair GJ, Posod A, et al. Levetiracetam increases neonatal hypoxic-ischemic brain injury under normothermic, but not hypothermic conditions. Brain Res. 2014;1556:10–8.

    Article  CAS  PubMed  Google Scholar 

  69. Strasser K, Lueckemann L, Kluever V, Thavaneetharajah S, Hoeber D, Bendix I, et al. Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain. Brain Res. 2016;1646:116–24.

    Article  CAS  PubMed  Google Scholar 

  70. Mruk AL, Garlitz KL, Leung NR. Levetiracetam in neonatal seizures: a review. J Pediatr Pharmacol Ther. 2015;20(2):76–89.

    PubMed  PubMed Central  Google Scholar 

  71. Sharpe CM, Capparelli EV, Mower A, Farrell MJ, Soldin SJ, Haas RH. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life. Pediatr Res. 2012;72(1):43–9.

    Article  CAS  PubMed  Google Scholar 

  72. Bye AM, Flanagan D. Spatial and temporal characteristics of neonatal seizures. Epilepsia. 1995;36(10):1009–16.

    Article  CAS  PubMed  Google Scholar 

  73. Ahrens S, Ream MA, Slaughter LA. Status epilepticus in the neonate: updates in treatment strategies. Curr Treat Options Neurol. 2019;21(2):8.

    Article  PubMed  Google Scholar 

  74. Iida Y, Nishi S, Asada A. Effect of mild therapeutic hypothermia on phenytoin pharmacokinetics. Ther Drug Monit. 2001;23(3):192–7.

    Article  CAS  PubMed  Google Scholar 

  75. Bhagat H, Bithal PK, Chouhan RS, Arora R. Is phenytoin administration safe in a hypothermic child? J Clin Neurosci. 2006;13(9):953–5.

    Article  CAS  PubMed  Google Scholar 

  76. Sheth RD, Buckley DJ, Gutierrez AR, Gingold M, Bodensteiner JB, Penney S. Midazolam in the treatment of refractory neonatal seizures. Clin Neuropharmacol. 1996;19(2):165–70.

    Article  CAS  PubMed  Google Scholar 

  77. Slaughter LA, Patel AD, Slaughter JL. Pharmacological treatment of neonatal seizures: a systematic review. J Child Neurol. 2013;28(3):351–64.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Shany E, Benzaqen O, Watemberg N. Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures. J Child Neurol. 2007;22(3):255–9.

    Article  PubMed  Google Scholar 

  79. van den Broek MP, van Straaten HL, Huitema AD, Egberts T, Toet MC, de Vries LS, et al. Anticonvulsant effectiveness and hemodynamic safety of midazolam in full-term infants treated with hypothermia. Neonatology. 2015;107(2):150–6.

    Article  PubMed  CAS  Google Scholar 

  80. Castro Conde JR, Hernandez Borges AA, Domenech Martinez E, Gonzalez Campo C, Perera SR. Midazolam in neonatal seizures with no response to phenobarbital. Neurology. 2005;64(5):876–9.

    Article  CAS  PubMed  Google Scholar 

  81. Weeke LC, Toet MC, van Rooij LG, Groenendaal F, Boylan GB, Pressler RM, et al. Lidocaine response rate in aEEG-confirmed neonatal seizures: retrospective study of 413 full-term and preterm infants. Epilepsia. 2015.

  82. Favie LMA, Huitema ADR, van den Broek MPH, Rademaker CMA, de Haan TR, van Straaten HLM, et al. Lidocaine as treatment for neonatal seizures: evaluation of previously developed population pharmacokinetic models and dosing regimen. Br J Clin Pharmacol. 2020;86(1):75–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. van den Broek MP, Groenendaal F, Toet MC, van Straaten HL, van Hasselt JG, Huitema AD, et al. Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach. Clin Pharmacokinet. 2012;51(10):671–9.

    Article  PubMed  CAS  Google Scholar 

  84. Flor-Hirsch H, Heyman E, Livneh A, Reish O, Watemberg N, Litmanovits I, et al. Lacosamide for SCN2A-related intractable neonatal and infantile seizures. Epileptic Disord. 2018;20(5):440–6.

    Article  PubMed  Google Scholar 

  85. Pisano T, Numis AL, Heavin SB, Weckhuysen S, Angriman M, Suls A, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015;56(5):685–91.

    Article  CAS  PubMed  Google Scholar 

  86. Sands TT, Balestri M, Bellini G, Mulkey SB, Danhaive O, Bakken EH, et al. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. Epilepsia. 2016;57(12):2019–30.

    Article  CAS  PubMed  Google Scholar 

  87. Cornet MC, Morabito V, Lederer D, Glass HC, Ferrao Santos S, Numis AL, et al. Neonatal presentation of genetic epilepsies: early differentiation from acute provoked seizures. Epilepsia. 2021;62(8):1907–20.

    Article  CAS  PubMed  Google Scholar 

  88. Wilson MP, Plecko B, Mills PB, Clayton PT. Disorders affecting vitamin B6 metabolism. J Inherit Metab Dis. 2019;42(4):629–46.

    Article  CAS  PubMed  Google Scholar 

  89. Mills PB, Footitt EJ, Mills KA, Tuschl K, Aylett S, Varadkar S, et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain. 2010;133(Pt 7):2148–59.

    Article  PubMed  PubMed Central  Google Scholar 

  90. van Karnebeek CD, Tiebout SA, Niermeijer J, Poll-The BT, Ghani A, Coughlin CR 2nd, et al. Pyridoxine-dependent epilepsy: an expanding clinical spectrum. Pediatr Neurol. 2016;59:6–12.

    Article  PubMed  Google Scholar 

  91. Coughlin CR 2nd, Tseng LA, Abdenur JE, Ashmore C, Boemer F, Bok LA, et al. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to alpha-aminoadipic semialdehyde dehydrogenase deficiency. J Inherit Metab Dis. 2021;44(1):178–92.

    Article  CAS  PubMed  Google Scholar 

  92. Stockler S, Plecko B, Gospe SM Jr, Coulter-Mackie M, Connolly M, van Karnebeek C, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104(1–2):48–60.

    Article  CAS  PubMed  Google Scholar 

  93. Cortes-Saladelafont E, Molero-Luis M, Hsjd Working G, Artuch R, Garcia-Cazorla A. Pyridoxal phosphate supplementation in neuropediatric disorders. Semin Pediatr Neurol. 2016;23(4):351–8.

    Article  PubMed  Google Scholar 

  94. Puri V, Ness S, Sattaluri SJ, Wang S, Todd M, Yuen E, et al. Long-term open-label study of adjunctive topiramate in infants with refractory partial-onset seizures. J Child Neurol. 2011;26(10):1271–83.

    Article  PubMed  Google Scholar 

  95. Glass HC, Poulin C, Shevell MI. Topiramate for the treatment of neonatal seizures. Pediatr Neurol. 2011;44(6):439–42.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Courchia B, Kurtom W, Pensirikul A, Del-Moral T, Buch M. Topiramate for seizures in preterm infants and the development of necrotizing enterocolitis. Pediatrics. 2018;142(1).

  97. Dzhala VI, Brumback AC, Staley KJ. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol. 2008;63(2):222–35.

    Article  CAS  PubMed  Google Scholar 

  98. Cleary RT, Sun H, Huynh T, Manning SM, Li Y, Rotenberg A, et al. Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures. PLoS One. 2013;8(3):e57148.

  99. Pressler RM, Boylan GB, Marlow N, Blennow M, Chiron C, Cross JH, et al. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Lancet Neurol. 2015;14(5):469–77.

    Article  CAS  PubMed  Google Scholar 

  100. Soul JS, Bergin AM, Stopp C, Hayes B, Singh A, Fortuno CR, et al. A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures. Ann Neurol. 2021;89(2):327–40.

    Article  CAS  PubMed  Google Scholar 

  101. Fitzgerald MP, Kessler SK, Abend NS. Early discontinuation of antiseizure medications in neonates with hypoxic-ischemic encephalopathy. Epilepsia. 2017;58(6):1047–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Jindal A, Angurana SK, Suthar R, Kumar P, Sundaram V. Effect of early withdrawal of phenobarbitone on the recurrence of neonatal seizures: an open-label randomized controlled trial. Epilepsy Behav. 2021;117:107875.

  103. Glass HC, Soul JS, Chang T, Wusthoff CJ, Chu CJ, Massey SL, et al. Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures. JAMA Neurol. 2021;78(7):817–25.

    Article  PubMed  Google Scholar 

  104. Pressler RM, Cilio MR, Mizrahi EM, Moshe SL, Nunes ML, Plouin P, et al. The ILAE classification of seizures and the epilepsies: modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia. 2021;62(3):615–28.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Chalia MD, MD research.

Ethics declarations

Conflict of interest

MC has nothing to declare or any conflicts of interest. HH reports serving as co-chair of the ILAE Pediatrics Commission task force ‘Guideline on Neonatal Seizures.’ RMP is also serving as co-chair of the ILAE Pediatrics Commission task force ‘Guideline on Neonatal Seizures.’ RMP reports personal fees and non-financial support from NATUS, personal fees from UCB, during the conduct of the study; personal fees from GW; from null, outside the submitted work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chalia, M., Hartmann, H. & Pressler, R. Practical Approaches to the Treatment of Neonatal Seizures. Curr Treat Options Neurol 24, 111–127 (2022). https://doi.org/10.1007/s11940-022-00711-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-022-00711-w

Keywords

Navigation